Scandinavian Real Heart

Scandinavian Real Heart is a Swedish publicly traded medtech company developing Realheart TAH, a total artificial heart intended for patients with end-stage heart failure, particularly those awaiting heart transplantation. The company’s core product is designed to mimic the anatomy, motion, and pulsatile blood flow of the natural human heart, with the goal of reducing complications such as hemolysis, stroke, bleeding, and anemia seen with existing mechanical circulatory support systems. Realheart has reported multiple successful preclinical implantations and animal studies and is building the data package required for a first-in-human clinical study. The company also develops associated controller and patient-support equipment for the implanted device. Its work is rooted in cardiovascular fluid dynamics research and collaborations with surgeons, engineers, and academic institutions.